Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc., sold ALKS on Jul 1, 2026
Data as of Oct 16
▼ SELL$427K8,300 shares at $51.46Craig C. Hopkinson EVP R&D, Chief Medical OfficerALKS Alkermes plc.
- Traded
- Jul 1, 2026
- Disclosed
- Jul 1, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ALKS since disclosure
−20.3%
after the sale
Similar stocks (XLV) since disclosure
+10.8%
XLV — its sector index fund
Change in closing price from Jul 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLCraig C. Hopkinson EVP R&D, Chief Medical OfficerALKS Alkermes plc.$36.5Kdisclosed Jul 1 · filed the same day